Pluripotency markers OCT4, SOX2 with cancer markers BRCA1, BRCA2, ER, PR and HER2 in breast cancer iPSCs; Tal2, EGF, ILF3, UBI2I, BRCA1 and BRCA2 in ovarian cancer iPSCs were analyzed. This evidence concerns the gene EGF and ovarian carcinoma.